|
|
Volumn 74, Issue 3, 2003, Pages 301-306
|
|
Psychopharmacological regulations. Results and commentary to the report on drug regulations 2002;Psychopharmakaverordnungen. Ergebnisse und kommentare zum arzneiverordnungsreport 2002
a
a
NONE
(Germany)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALMOTRIPTAN;
AMISULPRIDE;
ANTIDEPRESSANT AGENT;
BUTYROPHENONE DERIVATIVE;
FLUSPIRILENE;
GALANTAMINE;
GENERIC DRUG;
GLATIRAMER;
HYPNOTIC SEDATIVE AGENT;
MAPROTILINE;
MIANSERIN;
MIRTAZAPINE;
MOCLOBEMIDE;
NEUROLEPTIC AGENT;
NOOTROPIC AGENT;
PHENOTHIAZINE DERIVATIVE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
REBOXETINE;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SULPIRIDE;
SUMATRIPTAN SUCCINATE;
THIOXANTHENE DERIVATIVE;
TRANQUILIZER;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VENLAFAXINE;
ZOTEPINE;
DEMENTIA;
DEPRESSION;
DRUG LEGISLATION;
PHARMACODYNAMICS;
PSYCHOPHARMACOLOGY;
PSYCHOTHERAPY;
REVIEW;
ARTICLE;
COST CONTROL;
DRUG COST;
DRUG UTILIZATION;
ECONOMICS;
GERMANY;
HEALTH INSURANCE;
HUMAN;
LEGAL ASPECT;
PUBLIC HEALTH;
STATISTICS;
COST SAVINGS;
DRUG COSTS;
DRUG UTILIZATION;
GERMANY;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
NATIONAL HEALTH PROGRAMS;
PSYCHOTROPIC DRUGS;
|
|
EID: 0037599463
PISSN: 00282804
EISSN: None
Source Type: Journal
DOI: 10.1007/s00115-003-1502-9 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
